GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ouro Fino Saude Animal Participacoes SA (BSP:OFSA3) » Definitions » EBIT

Ouro Finoude Animal Participacoes (BSP:OFSA3) EBIT : R$91.7 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Ouro Finoude Animal Participacoes EBIT?

Ouro Finoude Animal Participacoes's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was R$37.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was R$91.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ouro Finoude Animal Participacoes's annualized ROC % for the quarter that ended in Dec. 2023 was 11.43%. Ouro Finoude Animal Participacoes's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 22.03%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ouro Finoude Animal Participacoes's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.09%.


Ouro Finoude Animal Participacoes EBIT Historical Data

The historical data trend for Ouro Finoude Animal Participacoes's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ouro Finoude Animal Participacoes EBIT Chart

Ouro Finoude Animal Participacoes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.56 107.75 145.32 184.51 91.84

Ouro Finoude Animal Participacoes Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.43 0.39 19.85 33.84 37.67

Competitive Comparison of Ouro Finoude Animal Participacoes's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Ouro Finoude Animal Participacoes's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ouro Finoude Animal Participacoes's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ouro Finoude Animal Participacoes's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ouro Finoude Animal Participacoes's EV-to-EBIT falls into.



Ouro Finoude Animal Participacoes EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$91.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ouro Finoude Animal Participacoes  (BSP:OFSA3) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ouro Finoude Animal Participacoes's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=150.048 * ( 1 - 34.26% )/( (836.244 + 889.259)/ 2 )
=98.6415552/862.7515
=11.43 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1269.599 - 164.74 - ( 268.615 - max(0, 321.636 - 806.147+268.615))
=836.244

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1279.009 - 85.721 - ( 304.029 - max(0, 232.656 - 828.889+304.029))
=889.259

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Ouro Finoude Animal Participacoes's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=150.66/( ( (342.369 + max(316.471, 0)) + (333.146 + max(375.936, 0)) )/ 2 )
=150.66/( ( 658.84 + 709.082 )/ 2 )
=150.66/683.961
=22.03 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(225.354 + 277.528 + 34.098) - (164.74 + 0 + 55.769)
=316.471

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(263.035 + 206.217 + 40.488) - (85.721 + 0 + 48.083)
=375.936

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ouro Finoude Animal Participacoes's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=91.741/1294.702
=7.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ouro Finoude Animal Participacoes EBIT Related Terms

Thank you for viewing the detailed overview of Ouro Finoude Animal Participacoes's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ouro Finoude Animal Participacoes (BSP:OFSA3) Business Description

Traded in Other Exchanges
N/A
Address
Anhanguera Highway SP 330, Km 298, Industrial District, Cravinhos, SP, BRA, 14140-000
Ouro Fino Saude Animal Participacoes SA is engaged in the production and sale of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses and goats and pets. The company reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimicrobials, Biological, Ectoparasiticides, Endectocides, Fortifiers / Supplements, and others.

Ouro Finoude Animal Participacoes (BSP:OFSA3) Headlines

No Headlines